Company Filing History:
1 out of 14 
1 out of 45 
Years Active: 2014
Title: Bart Anna Julien Maes: Innovator in HIV Research
Introduction
Bart Anna Julien Maes is a notable inventor based in Rumst, Belgium. He has made significant contributions to the field of HIV research, particularly through his innovative methods and tools for assessing viral fitness. His work is crucial in understanding HIV replicative capacity and its implications for treatment and diagnostics.
Latest Patents
Maes holds a patent titled "Methods, plasmid vectors and primers for assessing HIV viral fitness." This invention relates to methods and means for evaluating HIV replicative capacity in various environments. The patent describes a growth competition assay that determines relative viral fitness using a recombinant tagged HIV-1 virus system. The methods utilize plasmid vectors, amplicons, primers, and probes, leading to the generation of replication-competent viruses. These methods and materials have potential applications in diagnostics, drug screening, pharmacogenetics, and drug development.
Career Highlights
Throughout his career, Bart Anna Julien Maes has worked with prominent companies in the biotechnology sector. He has been associated with Speedx Pty Ltd and Janssen R&D Ireland, where he contributed to advancing research in HIV and related fields. His expertise and innovative approaches have made a significant impact on the scientific community.
Collaborations
Maes has collaborated with several professionals in his field, including Laurence Tatiana Rimsky and Inky Paul Madeleine De Baere. These collaborations have further enhanced his research and development efforts in HIV studies.
Conclusion
Bart Anna Julien Maes is a distinguished inventor whose work in HIV research has led to valuable advancements in understanding viral fitness. His contributions through patents and collaborations continue to influence the field significantly.